DMD is a rare, progressive genetic disorder characterised by the degeneration and weakness of muscles. Credit: Raja GamerXTC via Shutterstock. RegenxBio has revealed plans to
Radiopharmaceutical therapy involves targeting cancer cells with a radioactive drug. Credit: elenabsl via Shutterstock. Novartis is bolstering its leadership in the radiopharmaceutical space by partnering
Transthyretin amyloidosis with cardiomyopathy (ATTR-CM) presents with symptoms primarily related to heart failure and impaired cardiac function. Credit: Rawpixel.com via Shutterstock. Intellia Therapeutics has announced
GlobalData market analysts predict that Elahere could generate up to $1.98bn in revenue for AbbVie by 2030. Credit: Skorzewiak via Shutterstock. The European Commission (EC)
Chronic spontaneous urticaria is a skin condition characterised by persistent, itchy hives that last six weeks or longer. Credit: wisely via Shutterstock. The US Food
The EMA’s Committee for Medicinal Products for Human Use has issued a positive recommendation for Eisai and Biogen’s Leqembi (lecanemab) as a treatment for Alzheimer’s
The EMA’s Committee for Medicinal Products for Human Use has issued a positive recommendation for Eisai and Biogen’s Leqembi (lecanemab) as a treatment for Alzheimer’s
The primary analysis of the IGNYTE-ESO trial comprises data from 64 patients with either synovial sarcoma or myxoid/round cell liposarcoma (MRCLS). Credit: Nadiia Lapshynska via Shutterstock. Adaptimmune’s
The AUGMENT-101 trial evaluated the safety and efficacy of revumenib in adults with relapsed or refractory mutant NPM1 AML. Credit: SeventyFour via Shutterstock. Syndax Pharmaceuticals
Novavax will begin enrolling participants into the Phase III trial of its Covid-19 and influenza combination vaccine. Credit: Cira123 via Shutterstock. Novavax has received the